로딩 중…
지수 로딩 중…
Scribe Therapeutics Inc. Common Stock
SCTX· NASDAQ· Health Care
$29.74+0.92%
2026-09-11
Valuation Metrics
Scribe Therapeutics Inc. Common Stock's Market Cap is $481M. Ranked #2809 of 3,118 in US market (top 90%), #1231 of 1,460 on NASDAQ (top 84%) by Market Cap.
Investment Metrics(as of 2026-09-11)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $481M | US#2,809/3,118 |
| Employees | 89 | US#2,656/3,118 |
| Performance | ||
| 1M Return | 29.25% | US#49/3,118 |
| From 52W High | -24.90% | US#1,834/3,118 |
| 1Y MDD | -23.65% | US#972/3,118 |
| Trading | ||
| Volume | 139,663 shares | US#2,647/3,118 |
| Trading Value | $4M | US#2,591/3,118 |
Company Info
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.